Global Medical Device Outsourcing Market 2024 by Company, Regions, Type and Application, Forecast to 2030Medical devices outsourcing is the practice of hiring a third party for different business purposes such as manufacturing, supply chain management, prototyping, and product designing. They help the OEM to decrease their production time and labor cost. Outsourcing of medical devices is comparatively a new concept to concentrate on the core skills of the business, such as technological and clinical advances. They have the ability to provide different services such as regulatory affair services, product testing, product maintenance services, product design & development, product maintenance services, and contract manufacturing. The global Medical Device Outsourcing market size was valued at US$ 84410 million in 2023 and is forecast to a readjusted size of USD 157960 million by 2030 with a CAGR of 9.5% during review period. Major producers in the sector include Cardinal Health Inc., Jabil and Heraeus Holding GmbH, which accounted for 15.52%, 9.03% and 8.17% of revenue...Read more | USD 3,480.00 |
Global LFA-based Cardiac Market 2024 by Company, Regions, Type and Application, Forecast to 2030Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds. Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage. The global LFA-based Cardiac market size was valued at US$ 4017 million in 2023 and is forecast to a readjusted size of USD 6719 million by 2030 with a CAGR of 7.7% during review period. The industry"s leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019. This report is a detailed...Read more | USD 3,480.00 |
Global Cefotaxime Sodium API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria. The global Cefotaxime Sodium API market size was valued at US$ 103 million in 2023 and is forecast to a readjusted size of USD 98 million by 2030 with a CAGR of -0.8% during review period. Market competition is intense. REYOUNG, Nectar Lifesciences, Medya Pharma, Sandoz, Kelun, etc. are the leaders of the industry,...Read more | USD 3,480.00 |
Global Medical Isotopes Market 2024 by Company, Regions, Type and Application, Forecast to 2030A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use. In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers. The global Medical Isotopes market size was valued at US$ 832 million in 2023 and is forecast to a readjusted size of USD 1064 million by 2030 with a CAGR of 3.6% during review period. Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an...Read more | USD 3,480.00 |
Global Diclofenac Sodium and Codeine Phosphate Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Clofenstein tablets is a compound moderate analgesic, used for the treatment of bone pain (bone and joint pain, fracture pain, orthopedic surgery pain and cancer bone metastasis pain, etc.), postoperative pain, etc., can be used as the second step in cancer three-step analgesic treatment.Each tablet contains 25mg of diclofenac sodium and 15mg of codeine phosphate. The global Diclofenac Sodium and Codeine Phosphate Tablets market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period. In China, Diclofenac Sodium and Codeine Phosphate Tablets key players include Reyoung Pharmaceutical Co. Ltd., Jinyang Pharmaceutical Factory, etc. North China is the largest market, with a share over 55%, followed by East China, and Northeast China, both have a share over 25 percent. In terms of product, 10 Piece/Box is the largest segment, with a share over 75%. And in terms of application, the...Read more | USD 3,480.00 |